TCM has informed about the board at their meeting held today has approved Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended 31st March, 2018, and recommend the final dividend of Re 0.30 (i.e. 30%) per equity share of the face value of Re 1 each for the financial year ended 31st March, 2018, subject to the approval of the shareholders at the ensuing Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.
